Schonfeld Strategic Advisors’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-25,500
| Closed | -$34K | – | 3061 |
|
|
2022
Q1 | $34K | Buy |
+25,500
| New | +$34K | ﹤0.01% | 2302 |
|
|
2019
Q4 | – | Sell |
-52,700
| Closed | -$220K | – | 1518 |
|
|
2019
Q3 | $220K | Sell |
52,700
-37,700
| -42% | -$157K | 0.01% | 885 |
|
|
2019
Q2 | $1.19M | Buy |
90,400
+27,400
| +43% | +$360K | 0.04% | 403 |
|
|
2019
Q1 | $600K | Buy |
+63,000
| New | +$600K | 0.02% | 642 |
|